Understanding affinity variation in the CD28/ CTLA-4 pathway and its impact on immune function.

了解 CD28/CTLA-4 通路中的亲和力变化及其对免疫功能的影响。

• 批准号: 2720581
• 金额: --
• 依托单位: University College London
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2720581
• 关键词: Understanding; affinity; variation; CD28; CTLA

The CD28-CTLA-4 system is central to the control of T cell immune responses. While CD28 is an activating receptor, CTLA-4 opposes this function, inhibiting responses. Indeed, genetic deficiency in CTLA-4 function results in autoimmunity and antibody blockade is used to stimulate immunity to cancer therapeutically.Despite their opposing functions, CD28 and CTLA-4 share two ligands, CD80 and CD86, which differ in both affinity and avidity characteristics. How these distinct ligand characteristics affect immune function is not understood. In this project we propose to explore how changes in ligand characteristics impact immune function. We will generate and characterize different ligand variants in order to study their impact in a range of immune settings.Antigen presenting cells (B cell lines) will be engineered to express different ligands and functional outcomes will be compared at different levels of ligand expression. We anticipate studying human T cell responses to different ligand combinations in vitro, measuring their effect on T cell activation, expansion, survival, cellular phenotype, cytokine production and differentiation. Experiments will be carried out both in the presence and absence of CTLA-4 expression. In addition, we will perform studies to measure how different ligands are controlled by CTLA-4 transendocytosis and how they affect regulatory T cell (Treg) homeostasis. The project will provide training and experience in molecular biology, immunology and cell biology via the cloning and expressing of ligand variants and the study of their immune function. Overall, the project will generate a detailed understanding of the relationship between the biophysical characteristics CD28 and CTLA-4 ligands and their regulation of immune cell function.

CD28-CTLA-4 系统是 T 细胞免疫反应控制的核心。 CD28 是一种激活受体，而 CTLA-4 则反对这种功能，抑制反应。事实上，CTLA-4 功能的遗传缺陷会导致自身免疫，而抗体阻断可用于在治疗上刺激对癌症的免疫。尽管 CD28 和 CTLA-4 的功能相反，但它们共享两个配体 CD80 和 CD86，它们的亲和力和亲和力特征都不同。这些独特的配体特征如何影响免疫功能尚不清楚。在这个项目中，我们建议探索配体特征的变化如何影响免疫功能。我们将生成并表征不同的配体变体，以便研究它们在一系列免疫环境中的影响。抗原呈递细胞（B 细胞系）将被设计为表达不同的配体，并且将在不同配体表达水平下比较功能结果。我们预计在体外研究人类 T 细胞对不同配体组合的反应，测量它们对 T 细胞活化、扩增、存活、细胞表型、细胞因子产生和分化的影响。实验将在存在和不存在 CTLA-4 表达的情况下进行。此外，我们将进行研究来测量 CTLA-4 转内吞作用如何控制不同的配体以及它们如何影响调节性 T 细胞 (Treg) 稳态。该项目将通过配体变体的克隆和表达以及其免疫功能的研究，提供分子生物学、免疫学和细胞生物学方面的培训和经验。总体而言，该项目将详细了解 CD28 和 CTLA-4 配体的生物物理特征及其对免疫细胞功能的调节之间的关系。